文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

衰弱与危重病患者后续残疾及死亡率的关系

Frailty and Subsequent Disability and Mortality among Patients with Critical Illness.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01
一句话结论在成人危重病患者中,临床衰弱量表评分越高,3个月和12个月死亡率及工具性日常生活活动残疾风险越高,且与年龄无关。

该研究纳入1040例成人危重病患者,入组时用临床衰弱量表(范围1分极健康至7分重度衰弱)评估衰弱,中位评分3分(四分位距3-5分),中位年龄62岁(四分位距53-72岁)。出院后3个月和12个月评估生命状态、工具性日常生活活动、基本日常生活活动和认知。校正年龄、性别、教育、合并症、基线残疾、基线认知、疾病严重度、谵妄、昏迷、脓毒症、机械通气和镇静/阿片类药物后,临床衰弱量表评分越高与死亡率越高独立相关(3个月P=0.01,12个月P<0.001),与工具性日常生活活动残疾风险越高独立相关(3个月P=0.04,12个月P=0.002),但与基本日常生活活动残疾和认知无关联。作者认为未来研究应探索对所有年龄危重病患者常规筛查临床衰弱,并开发测试减少高脆弱性患者死亡和残疾的干预措施。

要点

  • 临床衰弱量表评分越高,危重病后3个月(P=0.01)和12个月(P<0.001)死亡率越高,且独立于年龄、合并症、疾病严重度等因素。
  • 临床衰弱量表评分越高,3个月(P=0.04)和12个月(P=0.002)工具性日常生活活动残疾风险越高,但与基本日常生活活动残疾无关联。
  • 临床衰弱(临床衰弱量表评分≥5分)患者中约一半年龄小于65岁,提示衰弱不限于老年患者。
  • 临床衰弱量表评分与认知功能无关联。
  • 作者认为未来研究应探索对所有年龄危重病患者常规筛查临床衰弱。

适用人群与场景

  • 年龄18岁及以上的危重病患者,入组时中位年龄62岁(四分位距53-72岁),中位临床衰弱量表评分3分(四分位距3-5分)。

诊断标准与关键阈值

  • 使用临床衰弱量表评估衰弱,范围1分(极健康)至7分(重度衰弱),临床衰弱定义为临床衰弱量表评分≥5分。

研究设计与关键结果

  • 研究纳入1040例成人危重病患者,入组时测量临床衰弱量表,出院后3个月和12个月评估生命状态、工具性日常生活活动、基本日常生活活动和认知。
  • 校正年龄、性别、教育、合并症、基线残疾、基线认知、疾病严重度、谵妄、昏迷、脓毒症、机械通气和镇静/阿片类药物后,临床衰弱量表评分越高与死亡率越高独立相关(3个月P=0.01,12个月P<0.001)。
  • 临床衰弱量表评分越高与工具性日常生活活动残疾风险越高独立相关(3个月P=0.04,12个月P=0.002)。
  • 临床衰弱量表评分与基本日常生活活动残疾和认知无关联。
  • 临床衰弱(临床衰弱量表评分≥5分)患者中约一半年龄小于65岁。

证据类型、等级与局限

  • 研究类型:多中心前瞻性队列研究(临床试验注册号NCT 00392795和NCT 00400062)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为未来研究应探索对所有年龄危重病患者常规筛查临床衰弱。
  • 作者认为应开发并测试减少高脆弱性患者死亡和残疾的干预措施。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: The prevalence of frailty (diminished physiologic reserve) and its effect on outcomes for those aged 18 years and older with critical illness is unclear.

OBJECTIVES: We hypothesized greater frailty would be associated with subsequent mortality, disability, and cognitive impairment, regardless of age.

METHODS: At enrollment, we measured frailty using the Clinical Frailty Scale (range, 1 [very fit] to 7 [severely frail]). At 3 and 12 months post-discharge, we assessed vital status, instrumental activities of daily living, basic activities of daily living, and cognition. We used multivariable regression to analyze associations between Clinical Frailty Scale scores and outcomes, adjusting for age, sex, education, comorbidities, baseline disability, baseline cognition, severity of illness, delirium, coma, sepsis, mechanical ventilation, and sedatives/opiates.

MEASUREMENTS AND MAIN RESULTS: We enrolled 1,040 patients who were a median (interquartile range) of 62 (53-72) years old and who had a median Clinical Frailty Scale score of 3 (3-5). Half of those with clinical frailty (i.e., Clinical Frailty Scale score ≥5) were younger than 65 years old. Greater Clinical Frailty Scale scores were independently associated with greater mortality (P = 0.01 at 3 mo and P < 0.001 at 12 mo) and with greater odds of disability in instrumental activities of daily living (P = 0.04 at 3 mo and P = 0.002 at 12 mo). Clinical Frailty Scale scores were not associated with disability in basic activities of daily living or with cognition.

CONCLUSIONS: Frailty is common in critically ill adults aged 18 years and older and is independently associated with increased mortality and greater disability. Future studies should explore routine screening for clinical frailty in critically ill patients of all ages. Interventions to reduce mortality and disability among patients with heightened vulnerability should be developed and tested. Clinical trial registered with www.clinicaltrials.gov (NCT 00392795 and NCT 00400062).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Brummel NE, Bell SP, Girard TD, et al. Frailty and Subsequent Disability and Mortality among Patients with Critical Illness. Am J Respir Crit Care Med. 2017. PMID: 27922747. doi:10.1164/rccm.201605-0939OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。